PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Chan Zuckerberg Initiative, Innovative Genomics Institute announce new Center for Pediatric CRISPR Cures

The Center will advance on-demand gene-editing cures for children with severe genetic diseases

2025-07-08
(Press-News.org) San Francisco — Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available. Today, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced the funding of the Center for Pediatric CRISPR Cures (Center). The Center will use CRISPR-based editing technology to advance cures for severe pediatric genetic diseases and will bridge CRISPR cure design and testing at the University of California, Berkeley (UC Berkeley) with clinical treatment at the University of California, San Francisco (UCSF). 

The new Center will build on recent clinical success in treating ‘Baby KJ’ Muldoon, an infant born with an exceedingly rare metabolic disease, with the first-ever personalized CRISPR gene-editing therapy. The IGI, a joint effort between UC Berkeley, UCSF and UC Davis founded by Nobel laureate Jennifer Doudna, played a critical role in developing and ensuring the safety of this breakthrough therapy. The IGI team collaborated with the University of Pennsylvania and the Children’s Hospital of Philadelphia caring for Baby KJ, as well as Danaher Corporation, whose operating companies Aldevron and Integrated DNA Technologies (IDT) manufactured components of the CRISPR therapy. IGI and Danaher have partnered over the past two years to create a blueprint for developing and delivering on-demand CRISPR therapies, one that could be used by organizations around the world for treating children with life-threatening genetic diseases.

“There is a natural alignment between the mission of the IGI to make CRISPR gene editing the standard of care for genetic diseases and CZI’s ambitious mission to help scientists cure all diseases,” said Doudna. “We’ve already seen the profound impact that an on-demand CRISPR therapy can have for one family, now we want to ensure that this approach can scale and be made available for more children around the world.” 

CZI’s support will allow the Center to apply the framework used for Baby KJ to help other children with ultra-rare diseases. The new Center will develop first-in-kind, personalized CRISPR on-demand treatments for children with severe inborn errors of immunity (IEI) and severe metabolic disease, with the initial aim of treating eight patients. This initiative will be the first step to achieve the larger, long-term goal of the Center to establish a standardized process for the delivery of this type of therapy so that many more families can access treatment.

“As a pediatrician trained at UCSF, a national referral center for children with rare diseases, I know firsthand the heartbreak of telling parents that we don’t understand their child’s illness or that we don’t know how to treat them,” said Dr. Priscilla Chan, co-CEO and co-founder of CZI. “For nearly a decade, CZI has supported rare disease communities through our Rare As One Project and Network, empowering patient-led organizations with the tools and resources they need to drive research and accelerate the search for treatments and cures. This new Center builds on that commitment and aims to bridge research to impact on the lives and futures of families facing ultra-rare diseases.”

The Center will coordinate the pre-clinical design and safety testing of CRISPR therapies to treat pediatric patients at UCSF’s Medical Center. The established treatment pipeline (pre-clinical, manufacturing, cell product, clinical and regulatory infrastructure) makes this work possible in just three years. The new Center, which will be funded by a $20 million grant from the Chan Zuckerberg Initiative, will demonstrate the strength of collaboration across the University of California and include Doudna, IGI-partnered clinicians at UCSF Dr. Chris Dvorak, Dr. Jennifer Puck, Dr. Irene Chang, and Dr. Brian Shy, and the IGI CRISPR Cures team at UC Berkeley led by Dr Fyodor Urnov that co-developed the CRISPR therapy for Baby KJ. Dr. Urnov will act as the director of the Center. The Center’s team combines expertise in childhood diseases, CRISPR therapy development, and clinical safety assessment. Danaher operating companies IDT, Aldevron, and Cytiva will collaborate to support the delivery of the necessary clinical-grade therapies.

With all appropriate confidentiality considerations, the Center will ensure that data from all investigative new drug-enabling studies, regulatory documentation, and clinical trials is available to other U.S. academic centers in pediatric disease that wish to design and deploy their own CRISPR-based therapies for similar cases. Additionally, IGI and CZI together will engage with patient communities, including those in the Rare As One Network, and other stakeholders to develop recommendations for making CRISPR cures more affordable and accessible.

 

About Innovative Genomics Institute 

Founded in 2015 by Nobel laureate Jennifer Doudna,  the Innovative Genomics Institute is a joint effort between three of California’s leading scientific research institutions, UC Berkeley, UC San Francisco, and UC Davis. The IGI’s diverse group of leading scientists is developing the next generation of genome engineering tools to treat human diseases, end hunger, and create a sustainable future. Learn more at innovativegenomics.org.

 

About the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges — from eradicating disease and improving education, to addressing the needs of our local communities. Our mission is to build a better future for everyone. For more information, please visit chanzuckerberg.com.

END


ELSE PRESS RELEASES FROM THIS DATE:

Innovative liquid biopsy test uses RNA to detect early-stage cancer

2025-07-08
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations or modification changes in fragments of DNA from cancer cells circulating in the blood. While liquid biopsies are a promising, non-invasive way to detect and monitor cancer as it progresses, they aren’t as sensitive or accurate for the early stages of disease. Researchers at the University of Chicago have now developed a more sensitive liquid biopsy test that uses RNA instead of DNA for detecting cancer. Using blood samples from patients with colorectal cancer, the test was able to detect ...

New quantum record: Transmon qubit coherence reaches millisecond threshold

2025-07-08
On July 8, 2025, physicists from Aalto University in Finland published a transmon qubit coherence dramatically surpassing previous scientifically published records. The millisecond coherence measurement marks a quantum leap in computational technology, with the previous maximum echo coherence measurements approaching 0.6 milliseconds.  Longer qubit coherence allows for an extended window of time in which quantum computers can execute error-free operations, enabling more complex quantum computations and more quantum logic operations before errors occur. Not only does this allow for more calculations with noisy quantum computers, but it also decreases the resources needed for ...

How Germany’s 2021 floods could have been even worse

2025-07-08
The devastating floods that killed nearly 200 people in Germany four years ago this month could have been even more damaging, new research suggests.  The floods in July 2021 were among the worst disasters in German history. At least 196 people died in Germany, 43 people died in Belgium and the total damage to Central Europe amounted to €46 billion. The devastation of the floods was attributed to a climate change-driven shift in the jet stream that steered a huge storm that became “cut off” ...

Study traces evolutionary origins of important enzyme complex

2025-07-08
University of Cincinnati Cancer Center researchers looked billions of years into the past to learn more about the potential future of precision medicine. Led by first author Bibek R. Karki and senior author Tom Cunningham, new research published July 8 in the journal Nature Communications traced the evolutionary origins of the PRPS enzyme complex and learned more about how this complex functions and influences cellular biochemistry. Study background The researchers focused on one of nature’s most important and evolutionarily ...

Tiny antibody has big impact on deadly viruses

2025-07-08
Researchers have discovered a strategy to neutralise two highly lethal viruses for which there is currently no approved vaccine or cure. A team led by Professor Daniel Watterson and Dr Ariel Isaacs at The University of Queensland has identified the first ever nanobody to work against Nipah and Hendra, henipaviruses which have jumped from animals to people in Asia and Australia. “A nanobody is one-tenth the size of an antibody and being that small it can access hard-to-reach areas of a virus to block infection,” Dr Isaacs said. “Nanobodies are also easier to produce and more stable at higher temperatures than traditional antibodies, so we are very excited about the potential ...

Scientists find new way to control electricity at tiniest scale

2025-07-08
Researchers at the University of California, Riverside, have uncovered how to manipulate electrical flow through crystalline silicon, a material at the heart of modern technology. The discovery could lead to smaller, faster, and more efficient devices by harnessing quantum electron behavior. At the quantum scale, electrons behave more like waves than particles. And now, scientists have shown that the symmetrical structure of silicon molecules can be fine-tuned to create, or suppress, a phenomenon known as destructive interference. The effect can turn conductivity “on” or “off,” functioning as a molecular-scale ...

Heat and heavy metals are changing the way that bees buzz

2025-07-08
Ongoing research into the effect of environmental change on the buzzing of bees reveals that high temperatures and exposure to heavy metals reduces the frequency (and audible pitch) of non-flight wing vibrations, which could have consequences on the effectiveness of bee communication and their role as pollinators. “People have been long interested in how insect flight muscles work, as these muscles power the most efficient flight systems in nature,” says Dr Charlie Woodrow, a post-doctoral researcher at Uppsala University. “However, many do not know that bees use these muscles for functions other than flight.” These ...

What’s behind the enormous increase in early-onset gastrointestinal cancers?

2025-07-08
A new paper in BJS, published by Oxford University Press, indicates that early-onset gastrointestinal cancer rates are rising dramatically across the globe. In the United States, the age-standardized rate of colorectal cancer decreased from 66.2 cases per 100,000 people in 1985 to 35.7 cases per 100,000 people in 2018. In contrast, early-onset colorectal cancer has shown a marked increase in both men and women in the United States since the mid-1990s, with the age-adjusted incidence rising from 5.9 cases per 100,000 in 2000 to 8.4 cases per 100,000 in 2017. Compared with adults born in 1950, those born in 1990 have twice the risk of ...

Pharmacogenomics expert advances precision medicine for bipolar disorder

2025-07-08
CAGLIARI, Sardinia, Italy, 8 July 2025 – In a comprehensive Genomic Press Interview published today in Genomic Psychiatry, Dr. Mirko Manchia opens up about his transformative journey from a small Sardinian city to becoming a leading voice in psychiatric pharmacogenomics, revealing how personal family experiences with mental illness sparked a lifelong quest to understand why psychiatric medications work brilliantly for some patients while failing others. The Associate Professor of Psychiatry at the University of Cagliari has spent decades unraveling one of psychiatry's most perplexing puzzles: why does lithium, psychiatry's oldest mood stabilizer, ...

Brazilian researcher explores centenarian stem cells for aging insights

2025-07-08
SÃO PAULO, São Paulo, Brazil, 8 July 2025 – In a comprehensive Genomic Press Interview, postdoctoral researcher Dr. Mateus Vidigal de Castro shares his contributions to longevity research at the University of São Paulo. Working under the supervision of Professor Mayana Zatz at one of Brazil's leading genetics research centers, Dr. de Castro studies induced pluripotent stem cells (iPSCs) derived from centenarians, particularly those who demonstrated recovery from COVID-19. Research ...

LAST 30 PRESS RELEASES:

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

ADHD drugs are being prescribed too quickly to preschoolers

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

Extreme heat linked to spike in domestic violence calls in New Orleans, study finds

Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients

Physiology-guided complete revascularization in older patients with myocardial infarction

Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations

[Press-News.org] Chan Zuckerberg Initiative, Innovative Genomics Institute announce new Center for Pediatric CRISPR Cures
The Center will advance on-demand gene-editing cures for children with severe genetic diseases